Larvol Delta - A-Clinical-Trial-Evaluating-TG4050-in-Head-and-Neck-Cancer

TG4050 - Transgene, NEC Corp

https://www.globenewswire.com/news-release/2024/10/07/2958646/0/en/Transgene-to-Present-a-Poster-on-Updated-Data-for-TG4050-at-SITC-2024.html

Oct 7, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next